International comparison of treatment and outcome in older patients with muscle-invasive bladder cancer.

被引：0
|
作者：
Extermann, Martine
Aben, Katja
Egan, Kathleen
de Craen, Anton J. M.
Van De Velde, Cornelis J. H.
Sexton, Wade Jeffers
Balducci, Lodovico
Liefers, Gerrit-Jan
Bastiaannet, Esther
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] Comprehens Canc Ctr Netherlands, Utrecht, Netherlands
[3] Leiden Univ, Med Ctr, Leiden, Netherlands
[4] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL 33612 USA
[5] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20517
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Challenges in the Modern Treatment of Muscle-Invasive Bladder Cancer
    Skinner, Eila C.
    ONCOLOGY-NEW YORK, 2011, 25 (14): : 1405 - 1406
  • [22] Treatment of muscle-invasive bladder cancer: is cystectomy enough?
    Lee, Cheryl T.
    Montie, James E.
    NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (03): : 126 - 127
  • [23] Treatment of muscle-invasive and advanced bladder cancer in 2020
    Patel, Vaibhav G.
    Oh, William K.
    Galsky, Matthew D.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2020, 70 (05) : 404 - 423
  • [24] Treatment of muscle-invasive bladder cancer: is cystectomy enough?
    Cheryl T Lee
    James E Montie
    Nature Clinical Practice Urology, 2007, 4 : 126 - 127
  • [25] Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer
    Zuiverloon, Tahlita C. M.
    Theodorescu, Dan
    PHARMACOGENOMICS, 2017, 18 (12) : 1167 - 1178
  • [26] Diagnostics and surgical treatment of muscle-invasive bladder cancer
    Niegisch, G.
    Kuebler, H.
    Gschwend, J. E.
    Heck, M.
    ONKOLOGE, 2018, 24 (01): : 32 - 39
  • [27] Prognosis of muscle-invasive bladder cancer. Differences between de novo and progressive patients
    Kiemeney, LA
    Schrier, B
    Hollander, M
    Van Rhijn, B
    Witjes, F
    JOURNAL OF UROLOGY, 2003, 169 (04) : 338 - 338
  • [28] The impact of pathologic downstaging with neoadjuvant chemotherapy on survival of patients with muscle-invasive bladder cancer.
    Martini, Alberto
    Heard, John R.
    Waingankar, Nikhil
    Jia, Rachel
    Sfakianos, John P.
    Galsky, Matthew
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [29] Bladder cancer susceptibility polymorphisms and mortality from non-muscle and muscle-invasive bladder cancer.
    Leeming, Reno C.
    Zens, Michael S.
    Seigne, John D.
    Christensen, Brock C.
    Gilbert-Diamond, Diane
    Karagas, Margaret R.
    Passarelli, Michael N.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 54 - 55
  • [30] Treatment of muscle-invasive bladder cancer: A systematic review
    Chou, Roger
    Selph, Shelley S.
    Buckley, David I.
    Gustafson, Katie S.
    Griffin, Jessica C.
    Grusing, Sara E.
    Gore, John L.
    CANCER, 2016, 122 (06) : 842 - 851
12345